2007
DOI: 10.1373/clinchem.2007.092296
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Homogeneous Assay to Measure Remnant Lipoprotein Cholesterol

Abstract: Background: Quantification of triglyceride-rich lipoprotein (TRL) remnants is useful for risk assessment of coronary artery disease and the diagnosis of type III hyperlipoproteinemia. Although an immunoseparation procedure for remnant-like particle cholesterol has been evaluated extensively in recent years, available methods for measuring TRL remnants have not achieved wide use in routine laboratory practice, suggesting a need for a homogeneous assay that can measure TRL remnant cholesterol in serum or plasma … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
46
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 51 publications
(47 citation statements)
references
References 23 publications
1
46
0
Order By: Relevance
“…Furthermore, the increased absorption of cholesterol and related phenomenon have been described in some populations at an elevated risk for atherosclerosis, such as those with obesity 18) , type 2 diabetes mellitus (T2DM) 19) and those treated with hemodialysis 20) . These previous studies raise the hypothesis that developed by Miyauchi et al 21) with commercial reagents (MetaboLead RemL-C test, Kyowa Medex Co., Ltd., Tokyo, Japan). The serum campesterol and lathosterol levels were measured as markers of intestinal cholesterol absorption and hepatic cholesterol synthesis, respectively, using gas chromatography at SRL,…”
Section: Subjectsmentioning
confidence: 64%
“…Furthermore, the increased absorption of cholesterol and related phenomenon have been described in some populations at an elevated risk for atherosclerosis, such as those with obesity 18) , type 2 diabetes mellitus (T2DM) 19) and those treated with hemodialysis 20) . These previous studies raise the hypothesis that developed by Miyauchi et al 21) with commercial reagents (MetaboLead RemL-C test, Kyowa Medex Co., Ltd., Tokyo, Japan). The serum campesterol and lathosterol levels were measured as markers of intestinal cholesterol absorption and hepatic cholesterol synthesis, respectively, using gas chromatography at SRL,…”
Section: Subjectsmentioning
confidence: 64%
“…This method utilized surfactant and phospholipase D to selectively solubilize and degrade remnant lipoprotein, while the RLP-C assay was an immune separation assay using an immunoaffinity gel containing antiapoA-1 and anti-apoB-100 monoclonal antibodies 22,23) . This RemL-C assay is adaptable for a universal clinical autoanalyzer, supplying quick and high-throughput measurements.…”
Section: Reml-c a Tg-independent Determinant For %Lipidmentioning
confidence: 99%
“…These remnant particles (CM-remnants and VLDL-remnants) directly infiltrate the vascular wall, subsequently triggering the development of atherosclerotic disease via accelerated macrophage foam cell formation, platelet coagulation and small dense LDL accumulation, as well as the induction of a low concentration of high-density lipoprotein (HDL) cholesterol (HDL-C) 5) . A number of remnant cholesterol assays have been developed and are currently being used to evaluate the risks of atherosclerotic diseases, such as cardiovascular disease (CAD) [6][7][8] . However, these methods cannot be used to accurately discriminate small intestine-derived CM-remnants from liver-derived VLDLremnants; therefore, the development of a new assay system is required in order to quantitatively measure the CM-remnant concentration independently.…”
Section: Measurementsmentioning
confidence: 99%